Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Syed Haider

Showing results (141-150 of 210) with videos related to

Pageof 21
Sort By:
EJIFCC|May 6, 2024
Artificial Intelligence - Perception of Clinical Laboratories' Technical Staff a Nationwide Multicentre Survey in PakistanSibtain Ahmed, Aqueel Kapadia, Imran Ahmed Siddiqui, et al.
Molecular Cancer Therapeutics|November 28, 2018
3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism ModifiersDylan T Jones, Alessandro Valli, Syed Haider, et al.
Cancer Research|October 6, 2023
Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast CancersArany Soosainathan, Marjan Iravani, Rania El-Botty, et al.
Nature Protocols|April 10, 2021
Identifying high-confidence capture Hi-C interactions using CHiCANEErle M Holgersen, Andrea Gillespie, Olivia C Leavy, et al.
Cancer Communications (London, England)|November 25, 2024
PTPN9 regulates HER3 phosphorylation during trastuzumab treatment and loss of PTPN9 is a potential biomarker for trastuzumab resistance in HER2 positive breast cancerAbul Azad, Maryam Arshad, Daniele Generali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2021
Assessing CSF ctDNA to Improve Diagnostic Accuracy and Therapeutic Monitoring in Breast Cancer Leptomeningeal MetastasisAmanda Fitzpatrick, Marjan Iravani, Adam Mills, et al.
Journal of Occupational and Environmental Medicine|January 25, 2020
The Pre-Registry Commercial Driver Medical Examination: Screening Sensitivity and Certification Lengths for Two Safety-Related Medical ConditionsStephen Vincent Burks, Jon Eugene Anderson, Bibhudutta Panda, et al.
Cell Genomics|February 1, 2025
Defining hypoxia in cancer: A landmark evaluation of hypoxia gene expression signaturesMatteo Di Giovannantonio, Fiona Hartley, Badran Elshenawy, et al.
Molecular Oncology|October 22, 2023
Cancer-associated FBXW7 loss is synthetic lethal with pharmacological targeting of CDC7Joseph S Baxter, Rachel Brough, Dragomir B Krastev, et al.
EJIFCC|June 30, 2025
Standardizing The Biochemical Tests for Chronic Kidney Disease (CKD): Where Do We Stand? A National Survey of Laboratories Across PakistanSibtain Ahmed, Fatima Muhammad Asad Khan, Ghazanfar Abbas, et al.
Pageof 21

Showing results (141-150 of 210) with videos related to

Sort By:
Pageof 21
EJIFCC|May 6, 2024
Artificial Intelligence - Perception of Clinical Laboratories' Technical Staff a Nationwide Multicentre Survey in PakistanSibtain Ahmed, Aqueel Kapadia, Imran Ahmed Siddiqui, et al.
Molecular Cancer Therapeutics|November 28, 2018
3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism ModifiersDylan T Jones, Alessandro Valli, Syed Haider, et al.
Cancer Research|October 6, 2023
Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast CancersArany Soosainathan, Marjan Iravani, Rania El-Botty, et al.
Nature Protocols|April 10, 2021
Identifying high-confidence capture Hi-C interactions using CHiCANEErle M Holgersen, Andrea Gillespie, Olivia C Leavy, et al.
Cancer Communications (London, England)|November 25, 2024
PTPN9 regulates HER3 phosphorylation during trastuzumab treatment and loss of PTPN9 is a potential biomarker for trastuzumab resistance in HER2 positive breast cancerAbul Azad, Maryam Arshad, Daniele Generali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2021
Assessing CSF ctDNA to Improve Diagnostic Accuracy and Therapeutic Monitoring in Breast Cancer Leptomeningeal MetastasisAmanda Fitzpatrick, Marjan Iravani, Adam Mills, et al.
Journal of Occupational and Environmental Medicine|January 25, 2020
The Pre-Registry Commercial Driver Medical Examination: Screening Sensitivity and Certification Lengths for Two Safety-Related Medical ConditionsStephen Vincent Burks, Jon Eugene Anderson, Bibhudutta Panda, et al.
Cell Genomics|February 1, 2025
Defining hypoxia in cancer: A landmark evaluation of hypoxia gene expression signaturesMatteo Di Giovannantonio, Fiona Hartley, Badran Elshenawy, et al.
Molecular Oncology|October 22, 2023
Cancer-associated FBXW7 loss is synthetic lethal with pharmacological targeting of CDC7Joseph S Baxter, Rachel Brough, Dragomir B Krastev, et al.
EJIFCC|June 30, 2025
Standardizing The Biochemical Tests for Chronic Kidney Disease (CKD): Where Do We Stand? A National Survey of Laboratories Across PakistanSibtain Ahmed, Fatima Muhammad Asad Khan, Ghazanfar Abbas, et al.
Pageof 21